MATINAS BIOPHARMA HOLDINGS, INC. Increase (Decrease) in Accounts Receivable, Related Parties
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase (Decrease) in Accounts Receivable, Related Parties of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2018-03-16
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2016-12-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2016-03-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2016 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2015 was -$45.64K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 9 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 derived: sum of 3 quarters · filed 2017-03-31 | $0.00 10-K · filed 2017-03-31 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | -$79.81K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | -$79.81K derived: sum of 3 quarters · filed 2018-03-16 | -$59.86K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | -$79.81K derived: sum of 2 quarters · filed 2018-03-16 | -$59.86K derived: sum of 3 quarters · filed 2018-03-16 | -$30.11K derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$79.81K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$59.86K derived: sum of 2 quarters · filed 2018-03-16 | -$30.11K derived: sum of 3 quarters · filed 2018-03-16 | -$45.64K 10-K · filed 2018-03-16 |
| 2015-09-30 | $19.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $49.70K derived: sum of 2 quarters · filed 2016-11-14 | $34.17K 10-Q · filed 2016-11-14 | $34.17K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $29.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $14.21K 10-Q · filed 2016-08-15 | $14.21K derived: sum of 3 quarters · filed 2016-08-15 | |
| 2015-03-31 | -$15.54K 10-Q · filed 2016-05-13 | -$15.54K derived: sum of 2 quarters · filed 2016-05-13 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |